H.C. Wainwright Downgrades Verrica Pharmaceuticals (VRCA) to Neutral
Tweet
Share
E-mailGet Alerts VRCA Hot Sheet
Price: $4.97 +2.26%
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Oren Livnat downgraded Verrica Pharmaceuticals (NASDAQ: VRCA) from Buy to Neutral.
For an analyst ratings summary and ratings history on Verrica Pharmaceuticals click here. For more ratings news on Verrica Pharmaceuticals click here.
Shares of Verrica Pharmaceuticals closed at $0.80 yesterday.
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Desjardins Downgrades Alithya Group Inc. (ALYA:CN) (ALYA) to Hold
- Citizens Downgrades SoundThinking (SSTI) to Market Perform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
